Table 1.
Main baseline characteristics of the study
| Items | HBV DNA undetected | Total | |
|---|---|---|---|
| At month 3 | >month 3 | ||
| Number of patients | 64 | 27 | 91 |
| Age (years) | 50.0 ± 11.2 | 47.9 ± 12.2 | 48.9 ± 11.6 |
| Gender (n (%)) | |||
| Male | 49 (76.6) | 19 (70.4) | 68 (74.7) |
| Alcohol consumption | |||
| history (n (%)) | |||
| No | 50 (78.1) | 24 (88.9) | 74 (81.3) |
| HBV DNA (log10) | 5.2 ± 1.4 | 6.8 ± 1.5 | 5.6 ± 1.6 |
| HBeAg* (n (%)) | |||
| Seronegative | 39 (62.9) | 8 (33.3) | 47 (54.7) |
| ALT (U/L) | 39 (10–281) | 66 (28–388) | 52 (10–388) |
| PLT (×109/L) | 103.6 ± 47.2 | 111.3 ± 66.6 | 92 (9–289) |
| T-Bil (μmol/L) | 19.2 (6.5–130.0) | 19.8 (9.6–174.3) | 19.2 (6.51–74.3) |
| ALB (g/L) | 40.2 ± 6.4 | 40.5 ± 9.4 | 40.3 ± 7.4 |
| PT (s) | 12.3 ± 1.4 | 12.1 ± 1.6 | 12.3 ± 1.4 |
| LSM (kPa) | 16.8 (4.6–72.0) | 11.6 (9.9–16.2) | 16.8 (4.6–72.0) |
Data are expressed as n (%), mean±SD or median (range), as appropriate. *No available data for five patients. HBV: Hepatitis B viral; HBeAg: Hepatitis B e antigen; ALT: Alanine aminotransferase; PLT: Blood platelet; T-Bil: Total bilirubin; ALB: Albumin; PT: Prothrombin time; LSM: Liver stiffness measurement; SD: Standard deviation.